Regulatory Compliance Failure: Non-compliance with strict healthcare regulations (e.g., FDA, EMA) for pharmaceutical packaging and medical devices could lead to fines, product recalls, operational shutdowns, and significant reputational damage, impacting their ability to sell products globally.

Product Quality and Liability Exposure: Defects in pharmaceutical primary packaging or drug delivery systems could result in patient harm, extensive product recalls, substantial product liability claims, and severe damage to customer trust and brand reputation.

Intense Market Competition: High competition from other specialized packaging and medical device manufacturers, coupled with pricing pressures from pharmaceutical and biotech clients, could erode profit margins and market share for Gerresheimer's products.